Concepedia

Dinko González Trotter

DG

Statistics

Publications

8

Citations

599

H-Index

8

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Purdue University West Lafayette

Vrije Universiteit Amsterdam

Regeneron (United States)

Amsterdam University Medical Centers

Dinko González Trotter is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, nuclear medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2000–2023

8

Publications

8

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 329 citations

, , +23

Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy

Gamal Akabani, Ilkcan Cokgor, Robert E. Coleman et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 69 citations

, , +8

Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

Maja Di Rocco, Eduardo Forleo‐Neto, Robert J. Pignolo et al. · Nature Medicine · 2023 · 45 citations · Full text

Synthesis and Preclinical Evaluation of Folate-NOTA-Al<sup>18</sup>F for PET Imaging of Folate-Receptor-Positive Tumors

Qingshou Chen, Xiangjun Meng, Paul McQuade et al. · Molecular Pharmaceutics · 2016 · 44 citations · Full text

Folate-PEG-NOTA-Al<sup>18</sup>F: A New Folate Based Radiotracer for PET Imaging of Folate Receptor-Positive Tumors

Qingshou Chen, Xiangjun Meng, Paul McQuade et al. · Molecular Pharmaceutics · 2017 · 33 citations

1–5 of 8